Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
Open Access
- 1 January 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (1) , 171-180
- https://doi.org/10.1038/mt.2009.208
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing EfficacyMolecular Therapy, 2009
- Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNACancer Research, 2008
- Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primatesProceedings of the National Academy of Sciences, 2008
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008
- Identification of a Common Gene Expression Response in Different Lung Inflammatory Diseases in Rodents and MacaquesPLOS ONE, 2008
- Optimum management of glucocorticoid-treated patientsNature Clinical Practice Endocrinology & Metabolism, 2008
- Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProceedings of the National Academy of Sciences, 2007
- Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesProceedings of the National Academy of Sciences, 2007
- Toll-like receptor signal transductionExperimental & Molecular Medicine, 2007
- RNAi: The Nuts and Bolts of the RISC MachineCell, 2005